Keywords
Last Name

Vincent Falanga, MD, FACP

TitleProfessor
InstitutionBoston University School of Medicine
DepartmentDermatology
Address25 Buick St
Boston MA 02215
Phone(401) 456-2590
ORCID ORCID Icon0000-0003-2292-2017
 Research Expertise & Professional Interests
A dedicated researcher, clinician, and educator, Dr. Vincent Falanga has had a longstanding relationship with the Boston University community. For the past 15 years, Dr. Falanga has been a Professor of Dermatology and Biochemistry at the Boston University School of Medicine (BUSM). In addition, he served as the Assistant Dean of Clinical and Faculty Affairs, as well as the Director of the Boston University Medical Students Ambulatory Medical Clerkship at Roger Williams Medical Center (RWMC), a research and clinical affiliate of the BUSM. From 1998 to 2013, he was the Chairman and Program Director of the Department of Dermatology at RWMC. Prior to that, Dr. Falanga held several academic appointments, including an initial one at the University of Pittsburgh School Of Medicine, and then as Professor of Dermatology and Medicine at the Miller School of Medicine at the University of Miami. A graduate of Harvard Medical School, Dr. Falanga received training in Internal Medicine and Dermatology at the University of Miami and the University of Pennsylvania, respectively. He is Board certified in both Medicine and Dermatology. In 2004, he was the President of the Wound Healing Society, the premier research organization in the world dedicated to wound healing.

Vincent Falanga’s remarkable research career began in the fields of molecular and cell biology, evolving over the years to groundbreaking human-based translational research. He made seminal contributions to the expansion and growth of single cells in low oxygen tension and to the effects and transcriptional regulation of transforming growth factor-ß 1 (TGF-ß1). Dr. Falanga later focused his efforts on human recombinant growth factors and was the first to use a recombinant growth factor (EGF) in human non-healing wounds. He showed that systemic anabolic steroids can heal the painful skin ulcers due to cryofibrinogenemia and that doubling the dose of systemically administered pentoxifylline will heal venous ulcers. In 1998, he was the lead author in the use of living bioengineered skin in non-healing wounds, which led to the first ever FDA approval of bioengineered skin for accelerating wound closure. In 2007, he was the first to successfully use autologous cultured bone marrow-derived mesenchymal stem cells in human chronic wounds. In his new role as the Department of Dermatology’s Vice Chair for Research, Dr. Falanga will spearhead and coordinate many of the research projects related to tissue injury, repair processes, and regeneration. The School of Medicine and the Department of Dermatology are currently building a Good Manufacturing Practice (GMP) facility in which Dr. Falanga will oversee the research and development of novel treatments utilizing the therapeutic potential of stem cells in the care of chronic wounds caused by disorders ranging from diabetes to autoimmune disease. The GMP facility promises to enrich the translational capabilities of the Medical Center in Dermatology and other specialties. His current project with stem cells in human wounds is funded by the National Institutes of Health, which has awarded Dr. Falanga more than $45 million over the course of his career.

 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Grada A, Falanga V. Cryofibrinogenemia-Induced Cutaneous Ulcers: A Review and Diagnostic Criteria. Am J Clin Dermatol. 2017 Feb; 18(1):97-104. PMID: 27734332.
    View in: PubMed
  2. Grada A, Otero-Vinas M, Prieto-Castrillo F, Obagi Z, Falanga V. Research Techniques Made Simple: Analysis of Collective Cell Migration Using the Wound Healing Assay. J Invest Dermatol. 2017 Feb; 137(2):e11-e16. PMID: 28110712.
    View in: PubMed
  3. Grada A, Falanga V. Novel Stem Cell Therapies for Applications to Wound Healing and Tissue Repair. Surg Technol Int. 2016 Oct 26; XXIX:29-37. PMID: 27728944.
    View in: PubMed
  4. Alani RM, Larson A, Falanga V. Paving a New Path Towards Academic Medicine-A Novel Approach to Graduate Medical Education in the United States. Acad Med. 2016 Aug; 91(8):1039-40. PMID: 27465087.
    View in: PubMed
  5. Mani R, Margolis DJ, Shukla V, Akita S, Lazarides M, Piaggesi A, Falanga V, Teot L, Xie T, Bing FX, Romanelli M, Attinger C, Han CM, Lu S, Meaume S, Xu Z, Viswanathan V. Optimizing Technology Use for Chronic Lower-Extremity Wound Healing: A Consensus Document. Int J Low Extrem Wounds. 2016 Jun; 15(2):102-19. PMID: 27207900.
    View in: PubMed
  6. Fournier JB, Dabiri G, Thomas V, Skowron G, Carson P, Falanga V. Serratia marcescens Bullous Cellulitis in a Splenectomized Patient: A Case Report and Review of the Literature. Int J Low Extrem Wounds. 2016 Jun; 15(2):161-8. PMID: 27079487.
    View in: PubMed
  7. Otero-Viñas M, Falanga V. Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced Therapy. Adv Wound Care (New Rochelle). 2016 Apr 01; 5(4):149-163. PMID: 27076993.
    View in: PubMed
  8. Lichtman MK, Otero-Vinas M, Falanga V. Transforming growth factor beta (TGF-ß) isoforms in wound healing and fibrosis. Wound Repair Regen. 2016 Mar; 24(2):215-22. PMID: 26704519.
    View in: PubMed
  9. Gould L, Abadir P, Brem H, Carter M, Conner-Kerr T, Davidson J, DiPietro L, Falanga V, Fife C, Gardner S, Grice E, Harmon J, Hazzard WR, High KP, Houghton P, Jacobson N, Kirsner RS, Kovacs EJ, Margolis D, McFarland Horne F, Reed MJ, Sullivan DH, Thom S, Tomic-Canic M, Walston J, Whitney JA, Williams J, Zieman S, Schmader K. Chronic wound repair and healing in older adults: current status and future research. J Am Geriatr Soc. 2015 Mar; 63(3):427-38. PMID: 25753048.
    View in: PubMed
  10. Gould L, Abadir P, Brem H, Carter M, Conner-Kerr T, Davidson J, DiPietro L, Falanga V, Fife C, Gardner S, Grice E, Harmon J, Hazzard WR, High KP, Houghton P, Jacobson N, Kirsner RS, Kovacs EJ, Margolis D, McFarland Horne F, Reed MJ, Sullivan DH, Thom S, Tomic-Canic M, Walston J, Whitney J, Williams J, Zieman S, Schmader K. Chronic wound repair and healing in older adults: current status and future research. Wound Repair Regen. 2015 Jan-Feb; 23(1):1-13. PMID: 25486905.
    View in: PubMed
  11. Carson P, Hong CJ, Otero-Vinas M, Arsenault EF, Falanga V. Liver enzymes and lipid levels in patients with lipodermatosclerosis and venous ulcers treated with a prototypic anabolic steroid (stanozolol): a prospective, randomized, double-blinded, placebo-controlled trial. Int J Low Extrem Wounds. 2015 Mar; 14(1):11-8. PMID: 25652757.
    View in: PubMed
  12. Lin X, Kwak T, Fiore D, Thompson PJ, Goodrich JK, Yufit T, Michalowski AM, Deschenes J, Carson P, Otero-Vinas M, Falanga V. An in vitro priming step increases the expression of numerous epidermal growth and migration mediators in a tissue-engineering construct. J Tissue Eng Regen Med. 2014 Dec 26. PMID: 25546487.
    View in: PubMed
  13. Chorzalska A, Salloum I, Shafqat H, Khan S, Marjon P, Treaba D, Schorl C, Morgan J, Bryke CR, Falanga V, Zhao TC, Reagan J, Winer E, Olszewski AJ, Al-Homsi AS, Kouttab N, Dubielecka PM. Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia. Leukemia. 2014 Nov; 28(11):2165-77. PMID: 24699303.
    View in: PubMed
  14. Yufit T, Carson P, Falanga V. Topical delivery of cultured stem cells to human non-healing wounds: GMP facility development in an academic setting and FDA requirements for an IND and human testing. Curr Drug Deliv. 2014; 11(5):572-81. PMID: 23517627.
    View in: PubMed
  15. Iwamoto S, Lin X, Ramirez R, Carson P, Fiore D, Goodrich J, Yufit T, Falanga V. Bone marrow cell mobilization by the systemic use of granulocyte colony-stimulating factor (GCSF) improves wound bed preparation. Int J Low Extrem Wounds. 2013 Dec; 12(4):256-64. PMID: 24275756.
    View in: PubMed
  16. Dabiri G, Hammerman S, Carson P, Falanga V. Low-grade elastic compression regimen for venous leg ulcers--an effective compromise for patients requiring daily dressing changes. Int Wound J. 2015 Dec; 12(6):655-61. PMID: 24267477.
    View in: PubMed
  17. Dabiri G, Heiner D, Falanga V. The emerging use of bone marrow-derived mesenchymal stem cells in the treatment of human chronic wounds. Expert Opin Emerg Drugs. 2013 Dec; 18(4):405-19. PMID: 24004161.
    View in: PubMed
  18. Licata LA, Nguyen CT, Burga RA, Falanga V, Espat NJ, Ayala A, Thorn M, Junghans RP, Katz SC. Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils. J Leukoc Biol. 2013 Oct; 94(4):813-23. PMID: 23883516.
    View in: PubMed
  19. Dabiri G, Falanga V. Connective tissue ulcers. J Tissue Viability. 2013 Nov; 22(4):92-102. PMID: 23756459.
    View in: PubMed
  20. Falanga V, Shen J. Growth Factors. Cutaneous Wound Healing. V Falanga editor. Martin Dunitz Publishers. London. 2013.
  21. Anderson-Dockter H, Clark T, Iwamoto S, Lu M, Fiore D, Falanga JK, Falanga V. Diagnostic utility of cytokeratin 17 immunostaining in morpheaform basal cell carcinoma and for facilitating the detection of tumor cells at the surgical margins. Dermatol Surg. 2012 Aug; 38(8):1357-66. PMID: 22691048.
    View in: PubMed
  22. Falanga V. Stem cells in tissue repair and regeneration. J Invest Dermatol. 2012 Jun; 132(6):1538-41. PMID: 22584501.
    View in: PubMed
  23. Kurniali PC, O'Gara K, Wang X, Wang LJ, Somasundar P, Falanga V, Espat NJ, Katz SC. The effects of sorafenib on liver regeneration in a model of partial hepatectomy. J Surg Res. 2012 Nov; 178(1):242-7. PMID: 22482755.
    View in: PubMed
  24. Falanga V, Iwamoto S. Wound repair: Mechanisms and practical considerations. Fitspatrick’s Dermatology in General Medicine. Eds. Wolff K, Goldsmith LS, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. Elsevier. 8th Edition. 2012.
  25. Falanga V, Iwamoto A. Preparation of the wound bed of the diabetic foot ulcer. The Diabetic Foot. Eds. Aris Veves, John M. Giurini, Fank W. LoGerfo. Human Press. 3rd Edition. Totowa, NJ. 2012.
  26. Falanga V, Lindholm C, Carson P, Panuncialman J, Mamakos L, Lotti T, Falanga J. Text Atlas of Wound Healing. Informa Healthcare. 2012.
  27. Luo S, Yufit T, Carson P, Fiore D, Falanga J, Lin X, Mamakos L, Falanga V. Differential keratin expression during epiboly in a wound model of bioengineered skin and in human chronic wounds. Int J Low Extrem Wounds. 2011 Sep; 10(3):122-9. PMID: 21856973.
    View in: PubMed
  28. Lazic T, Falanga V. Bioengineered skin constructs and their use in wound healing. Plast Reconstr Surg. 2011 Jan; 127 Suppl 1:75S-90S. PMID: 21200276.
    View in: PubMed
  29. Panuncialman J, Falanga V. Unusual causes of cutaneous ulceration. Surg Clin North Am. 2010 Dec; 90(6):1161-80. PMID: 21074034.
    View in: PubMed
  30. Gillespie DL. Venous ulcer diagnosis, treatment, and prevention of recurrences. J Vasc Surg. 2010 Nov; 52(5 Suppl):8S-14S. PMID: 20678885.
    View in: PubMed
  31. Li L, Iwamoto S. Diabetic foot ulcer calluses show histological similarities to HPV infection without evidence of HPV involvement by nested PCR. Int J Low Extrem Wounds. 2010 Jun; 9(2):84-9. PMID: 20483807.
    View in: PubMed
  32. Panuncialman J, Hammerman S, Carson P, Falanga V. Wound edge biopsy sites in chronic wounds heal rapidly and do not result in delayed overall healing of the wounds. Wound Repair Regen. 2010 Jan-Feb; 18(1):21-5. PMID: 20082677.
    View in: PubMed
  33. Panuncialman J, Falanga V. The science of wound bed preparation. Surg Clin North Am. 2009 Jun; 89(3):611-26. PMID: 19465200.
    View in: PubMed
  34. Iwamoto S, Iwamoto AT, Cha J, Clark T, Lu M, Breen C, Bhawan J, Falanga V. The utility of the DNA microarray scanner to simplify the immunofluorescence evaluation of autoimmune bullous diseases. Am J Dermatopathol. 2009 May; 31(3):218-22. PMID: 19384060.
    View in: PubMed
  35. Falanga V. Bone marrow cells can manipulate healing. Blood. 2009 Jan 29; 113(5):982-3. PMID: 19179473.
    View in: PubMed
  36. Chartier M, Falanga V. Healing of ulcers due to cryofibrinogenemia with colchicine and high-dose pentoxifylline. Am J Clin Dermatol. 2009; 10(1):39-42. PMID: 19170411.
    View in: PubMed
  37. McClain SE, Goldenberg G, Falanga V, Jorizzo JL. Scleroderma, Raynaud’s Phenomenon, and Related Conditions. Dermatological Signs of Internal Disease. Edited by Jeffrey P. Callen, Joseph L. Jorizzo, Jean L. Bolognia, Warren W. Piette, John J. Zone. Saunders Elsevier. 2009; 21-29.
  38. Panuncialman J, Falanga V. Venous leg ulcers. Conn’s Current Therapy. Elsevier. 2009; 855-857.
  39. Massé M, Falanga V, Zhou LH. Use of topical povidone-iodine resulting in an iododerma-like eruption. J Dermatol. 2008 Nov; 35(11):744-7. PMID: 19120771.
    View in: PubMed
  40. Kobrin KL, Thompson PJ, van de Scheur M, Kwak TH, Kim S, Falanga V. Evaluation of dermal pericapillary fibrin cuffs in venous ulceration using confocal microscopy. Wound Repair Regen. 2008 Jul-Aug; 16(4):503-6. PMID: 18638268.
    View in: PubMed
  41. Falanga V, Brem H, Ennis WJ, Wolcott R, Gould LJ, Ayello EA. Maintenance debridement in the treatment of difficult-to-heal chronic wounds. Recommendations of an expert panel. Ostomy Wound Manage. 2008 Jun; Suppl:2-13; quiz 14-5. PMID: 18980069.
    View in: PubMed
  42. Falanga V, Chartier M, Butmarc J, Tibbetts L. Collision of desmoplastic-neurotropic melanoma and squamous cell carcinoma on the lip. J Cutan Pathol. 2008 May; 35(5):473-6. PMID: 18399808.
    View in: PubMed
  43. Falanga V. Measurements in wound healing. Int J Low Extrem Wounds. 2008 Mar; 7(1):9-11. PMID: 18372262.
    View in: PubMed
  44. Falanga V, Iwamoto S. Wound repair: Mechanisms and practical considerations. Fitzpatrick’s Dermatology in General Medicine. Eds. Wolff K, Goldmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. McGraw Hill,7th Edition. New York, NY. 2008; 2342-2349.
  45. Falanga V, Killoran CE. Morphea. Fitzpatrick’s Dermatology in General Medicine. Eds. Wolff K, Goldmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. McGraw Hill,7th Edition. New York, NY. 2008; 543-546.
  46. Cha J, Falanga V. Transforming growth factor-ß in cutaneous tissue repair. Transforming Growth Factor-ß in Cancer Therapy. Ed. Sonia B. Jakowlew. Humana Press. 2008; 675-691.
  47. Cha J, Kwak T, Butmarc J, Kim TA, Yufit T, Carson P, Kim SJ, Falanga V. Fibroblasts from non-healing human chronic wounds show decreased expression of beta ig-h3, a TGF-beta inducible protein. J Dermatol Sci. 2008 Apr; 50(1):15-23. PMID: 18078741.
    View in: PubMed
  48. Panuncialman J, Falanga V. The science of wound bed preparation. Clin Plast Surg. 2007 Oct; 34(4):621-32. PMID: 17967618.
    View in: PubMed
  49. Falanga V, Iwamoto S, Chartier M, Yufit T, Butmarc J, Kouttab N, Shrayer D, Carson P. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 2007 Jun; 13(6):1299-312. PMID: 17518741.
    View in: PubMed
  50. Ingraffea A, Donohue K, Wilkel C, Falanga V. Cutaneous vasculitis in two patients taking an herbal supplement containing black cohosh. J Am Acad Dermatol. 2007 May; 56(5 Suppl):S124-6. PMID: 17434040.
    View in: PubMed
  51. Cha J, Falanga V. Stem cells in cutaneous wound healing. Clin Dermatol. 2007 Jan-Feb; 25(1):73-8. PMID: 17276204.
    View in: PubMed
  52. Falanga V, Faria K. Bioengineered skin constructs. Principles of Tissue Engineering. 3rd Edition. Editors: Robert Lanza, Robert Langer, Joseph P. Vacanti. Elsevier. New York, NY. 2007; 1167-1186.
  53. Falanga V, Butmarc J, Cha J, Yufit T, Carson P. Migration of the epidermal over the dermal component (epiboly) in a bilayered bioengineered skin construct. Tissue Eng. 2007 Jan; 13(1):21-8. PMID: 17518578.
    View in: PubMed
  54. Sibbald GR, Williamson D, Contreras-Ruiz J, Burrows C, Despalis M, Falanga V, Cherry GW. Chronic Wound Care, 4th Edition, editors Krasner DL, Rodeheaver GT, Sibbald GR, chapter 44. HMP Communication. Malvern, PA. 2007; 429-442.
  55. Falanga V, Saap LJ, Ozonoff A. Wound bed score and its correlation with healing of chronic wounds. Dermatol Ther. 2006 Nov-Dec; 19(6):383-90. PMID: 17199681.
    View in: PubMed
  56. Panuncialman J, Falanga V. Basic approach to inflammatory ulcers. Dermatol Ther. 2006 Nov-Dec; 19(6):365-76. PMID: 17199679.
    View in: PubMed
  57. Kissin EY, Schiller AM, Gelbard RB, Anderson JJ, Falanga V, Simms RW, Korn JH, Merkel PA. Durometry for the assessment of skin disease in systemic sclerosis. Arthritis Rheum. 2006 Aug 15; 55(4):603-9. PMID: 16874783.
    View in: PubMed
  58. Hu S, Kirsner RS, Falanga V, Phillips T, Eaglstein WH. Evaluation of Apligraf persistence and basement membrane restoration in donor site wounds: a pilot study. Wound Repair Regen. 2006 Jul-Aug; 14(4):427-33. PMID: 16939570.
    View in: PubMed
  59. Cavorsi J, Vicari F, Wirthlin DJ, Ennis W, Kirsner R, O'Connell SM, Steinberg J, Falanga V. Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers. Wound Repair Regen. 2006 Mar-Apr; 14(2):102-9. PMID: 16630097.
    View in: PubMed
  60. Falanga V. Pressure ulcers and wound bed preparation. Science and Practice of Pressure Ulcer Management, ed. Marco Romanelli. Springer-Verlag. London. 2006; 99-109.
  61. Falanga V. Preparation of the wound bed of the diabetic foot ulcer. The Diabetic Foot. Eds. Aris Veves, John M. Giurini, Fank W. LoGerfo. 2nd Edition,Human Press. Totowa, NJ. 2006; 299-310.
  62. Falanga V (ed.). Wound Healing. Dermatologic Therapy. Blackwell Publishing. Oxford, UK. 2006; 19.
  63. Nori S, Greene MA, Schrager HM, Falanga V. Infectious occupational exposures in dermatology--a review of risks and prevention measures. I. For all dermatologists. J Am Acad Dermatol. 2005 Dec; 53(6):1010-9. PMID: 16310062.
    View in: PubMed
  64. Nori S, Greene MA, Schrager HM, Falanga V. Infectious occupational exposures in dermatology--a review of risks and prevention measures. II. The pregnant dermatologist. J Am Acad Dermatol. 2005 Dec; 53(6):1020-6. PMID: 16310063.
    View in: PubMed
  65. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005 Nov 12; 366(9498):1736-43. PMID: 16291068.
    View in: PubMed
  66. Donohue KG, Carson P, Iriondo M, Zhou L, Saap L, Gibson K, Falanga V. Safety and efficacy of a bilayered skin construct in full-thickness surgical wounds. J Dermatol. 2005 Aug; 32(8):626-31. PMID: 16334861.
    View in: PubMed
  67. Massé M, Cserhalmi-Friedman PB, Falanga V, Celebi JT, Martinez-Mir A, Christiano AM. Identification of novel type VII collagen gene mutations resulting in severe recessive dystrophic epidermolysis bullosa. Clin Exp Dermatol. 2005 May; 30(3):289-93. PMID: 15807692.
    View in: PubMed
  68. Donohue KG, Falanga V. Skin substitutes in acute and chronic wounds. Manual of Wound Management and Heaing. Ed. Bok Lee. McGraw-Hill. New York, NY. 2005; 298-308.
  69. Saap L, Fahim S, Arsenault E, Pratt M, Pierscianowski T, Falanga V, Pedvis-Leftick A. Contact sensitivity in patients with leg ulcerations: a North American study. Arch Dermatol. 2004 Oct; 140(10):1241-6. PMID: 15492187.
    View in: PubMed
  70. Saap LJ, Donohue K, Falanga V. Clinical classification of bioengineered skin use and its correlation with healing of diabetic and venous ulcers. Dermatol Surg. 2004 Aug; 30(8):1095-100. PMID: 15274699.
    View in: PubMed
  71. Nahm WK, Philpot BD, Adams MM, Badiavas EV, Zhou LH, Butmarc J, Bear MF, Falanga V. Significance of N-methyl-D-aspartate (NMDA) receptor-mediated signaling in human keratinocytes. J Cell Physiol. 2004 Aug; 200(2):309-17. PMID: 15174101.
    View in: PubMed
  72. Brem H, Kirsner RS, Falanga V. Protocol for the successful treatment of venous ulcers. Am J Surg. 2004 Jul; 188(1A Suppl):1-8. PMID: 15223495.
    View in: PubMed
  73. Butmarc J, Yufit T, Carson P, Falanga V. Human beta-defensin-2 expression is increased in chronic wounds. Wound Repair Regen. 2004 Jul-Aug; 12(4):439-43. PMID: 15260809.
    View in: PubMed
  74. Falanga V, Schrayer D, Cha J, Butmarc J, Carson P, Roberts AB, Kim SJ. Full-thickness wounding of the mouse tail as a model for delayed wound healing: accelerated wound closure in Smad3 knock-out mice. Wound Repair Regen. 2004 May-Jun; 12(3):320-6. PMID: 15225210.
    View in: PubMed
  75. Ayello EA, Dowsett C, Schultz GS, Sibbald RG, Falanga V, Harding K, Romanelli M, Stacey M, TEot L, Vanscheidt W. TIME heals all wounds. Nursing. 2004 Apr; 34(4):36-41; quiz, 41-2. PMID: 15247672.
    View in: PubMed
  76. Eberting CL, Shrayer DP, Butmarc J, Falanga V. Histologic progression of B16 F10 metastatic melanoma in C57BL/6 mice over a six week time period: distant metastases before local growth. J Dermatol. 2004 Apr; 31(4):299-304. PMID: 15187325.
    View in: PubMed
  77. Falanga V. The chronic wound: impaired healing and solutions in the context of wound bed preparation. Blood Cells Mol Dis. 2004 Jan-Feb; 32(1):88-94. PMID: 14757419.
    View in: PubMed
  78. Donohue KG, Saap L, Falanga V. Cholesterol crystal embolization: an atherosclerotic disease with frequent and varied cutaneous manifestations. J Eur Acad Dermatol Venereol. 2003 Sep; 17(5):504-11. PMID: 12941082.
    View in: PubMed
  79. Quesenberry PJ, Colvin GA, Abedi M, Lambert JF, Moore B, Demers D, Greer D, McAuliffe C, Dooner M, Lum LG, Badiavas E, Falanga V. The marrow stem cell: the continuum. Bone Marrow Transplant. 2003 Aug; 32 Suppl 1:S19-22. PMID: 12931234.
    View in: PubMed
  80. Badiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol. 2003 Aug; 196(2):245-50. PMID: 12811816.
    View in: PubMed
  81. Kim BC, Kim HT, Park SH, Cha JS, Yufit T, Kim SJ, Falanga V. Fibroblasts from chronic wounds show altered TGF-beta-signaling and decreased TGF-beta Type II receptor expression. J Cell Physiol. 2003 Jun; 195(3):331-6. PMID: 12704642.
    View in: PubMed
  82. Paquette DL, Falanga V. Cutaneous concerns of scleroderma patients. J Dermatol. 2003 Jun; 30(6):438-43. PMID: 12810990.
    View in: PubMed
  83. Shen JT, Falanga V. Innovative therapies in wound healing. J Cutan Med Surg. 2003 May-Jun; 7(3):217-24. PMID: 12704530.
    View in: PubMed
  84. Falanga V. Wound bed preparation: future approaches. Ostomy Wound Manage. 2003 May; 49(5A Suppl):30-3. PMID: 12883163.
    View in: PubMed
  85. Quesenberry P, Colvin G, Lambert JF, Abedi M, Cerny J, Dooner M, Moore B, McAuliffe C, Demers D, Greer D, Parent A, Badiavas E, Lum L, Falanga V. Marrow stem cell potential within a continuum. Ann N Y Acad Sci. 2003 May; 996:209-21. PMID: 12799298.
    View in: PubMed
  86. Badiavas EV, Falanga V. Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol. 2003 Apr; 139(4):510-6. PMID: 12707099.
    View in: PubMed
  87. Nahm WK, Donohue KG, Danahy JF, Badiavas E, Falanga V. Systemic 5-fluorouracil producing an inflammatory response in porokeratosis. J Eur Acad Dermatol Venereol. 2003 Mar; 17(2):190-2. PMID: 12705749.
    View in: PubMed
  88. Schultz GS, Sibbald RG, Falanga V, Ayello EA, Dowsett C, Harding K, Romanelli M, Stacey MC, Teot L, Vanscheidt W. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003 Mar; 11 Suppl 1:S1-28. PMID: 12654015.
    View in: PubMed
  89. Falanga V (ed.). New Concepts in Wound Bed Preparation. Springer-Verlag GmbH & Co. KG. New York. 2003.
  90. Shen JT, Falanga V. Growth factors, signal transduction, and cellular responses. J Dermatol. 2003 Jan; 30(1):5-16. PMID: 12598704.
    View in: PubMed
  91. Falanga V. Systemic sclerosis (scleroderma). Dermatology. Eds. Bolognia JL, Jorizzo JL, Rapini RP. Mosby/Elsevier. Philadelphia, PA. 2003; 625-632.
  92. Quesenberry PJ, Lambert JF, Colvin GA, Dooner M, McAuliffe CI, Abedi M, Greer D, Demers D, Cerny J, Moore BE, Badiavas E, Falanga V. The stem cell continuum: A plastic plasticity. Stem Cell Therapy for Autoimmune Disease, ed. Richard K. Burt. Landes Bioscience/Eurekah.com. 2003; 91-94.
  93. Falanga V, Jorizzo JL. Scleroderma, Raynaud’s phenomenon, and related conditions. Dermatologcial Signs of Internal Disease, editors Callen JP, Jorizzo JL, Bolognia JL, Piette WW, Zone JJ. W.B. Saunders. Philadelphia, PA. 2003; 17-23.
  94. Falanga V. Mechanisms of cutaneous wound repair. Fitzpatrick’s Dermatology in General Medicine, eds. Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI. Sixth Edition. McGraw-Hill. New York, NY. 2003; 236-246.
  95. Saap LJ, Falanga V. Debridement performance index and its correlation with complete closure of diabetic foot ulcers. Wound Repair Regen. 2002 Nov-Dec; 10(6):354-9. PMID: 12453138.
    View in: PubMed
  96. Stacey M, Falanga V, Marston W, Moffat C, Phillips T, Sibbald RG, Vanscheidt W, Lindholm C. Compression therapy in the treatment of venous leg ulcers. Nurs Times. 2002 Sep 3-9; 98(36):39-43. PMID: 12244668.
    View in: PubMed
  97. Falanga V, Isaacs C, Paquette D, Downing G, Kouttab N, Butmarc J, Badiavas E, Hardin-Young J. Wounding of bioengineered skin: cellular and molecular aspects after injury. J Invest Dermatol. 2002 Sep; 119(3):653-60. PMID: 12230509.
    View in: PubMed
  98. Phillips TJ, Manzoor J, Rojas A, Isaacs C, Carson P, Sabolinski M, Young J, Falanga V. The longevity of a bilayered skin substitute after application to venous ulcers. Arch Dermatol. 2002 Aug; 138(8):1079-81. PMID: 12164746.
    View in: PubMed
  99. Badiavas EV, Paquette D, Carson P, Falanga V. Human chronic wounds treated with bioengineered skin: histologic evidence of host-graft interactions. J Am Acad Dermatol. 2002 Apr; 46(4):524-30. PMID: 11907501.
    View in: PubMed
  100. Nahm WK, Badiavas E, Touma DJ, Wilkel CS, Falanga V. Calciphylaxis with peau d'orange induration and absence of classical features of purpura, livedo reticularis and ulcers. J Dermatol. 2002 Apr; 29(4):209-13. PMID: 12027085.
    View in: PubMed
  101. Falanga V, Zhou L, Yufit T. Low oxygen tension stimulates collagen synthesis and COL1A1 transcription through the action of TGF-beta1. J Cell Physiol. 2002 Apr; 191(1):42-50. PMID: 11920680.
    View in: PubMed
  102. Zhou LH, Nahm WK, Badiavas E, Yufit T, Falanga V. Slow release iodine preparation and wound healing: in vitro effects consistent with lack of in vivo toxicity in human chronic wounds. Br J Dermatol. 2002 Mar; 146(3):365-74. PMID: 11952535.
    View in: PubMed
  103. Paquette D, Falanga V. Leg ulcers. Clin Geriatr Med. 2002 Feb; 18(1):77-88, vi. PMID: 11913740.
    View in: PubMed
  104. Nahm WK, Zhou L, Falanga V. Sustained ability for fibroblast outgrowth from stored neonatal foreskin: a model for studying mechanisms of fibroblast outgrowth. J Dermatol Sci. 2002 Feb; 28(2):152-8. PMID: 11858954.
    View in: PubMed
  105. Paquette D, Falanga V. Leg Ulcers. Clinics in Geriatric Medicine, Geriatric Dermatology, Part II. Ed. Barbara A. Gilchrest. W.B. Saunders. Philadelphia, PA. 2002; 77-88.
  106. Quesenberry PJ, Colvin GA, Lambert JF, Frimberger AE, Dooner MS, Mcauliffe CI, Miller C, Becker P, Badiavas E, Falanga VJ, Elfenbein G, Lum LG. The new stem cell biology. Trans Am Clin Climatol Assoc. 2002; 113:182-206; discussion 206-7. PMID: 12053709.
    View in: PubMed
  107. Romanelli M, Falanga V. Hardware and Measuring Principles: The Durometer. Bioengineering of the Skin. Skin Biomechanics. Eds. Peter Elsner, Enzo Berardesca, Klaus-P Wilhelm, Howard I. Maybach. CRC Press. New York, New York. 2002; 139-145.
  108. Nahm WK, Tsoukas MM, Falanga V, Carson PA, Sami N, Touma DJ. Preliminary study of fine changes in the duration of dynamic cooling during 755-nm laser hair removal on pain and epidermal damage in patients with skin types III-V. Lasers Surg Med. 2002; 31(4):247-51. PMID: 12355569.
    View in: PubMed
  109. Falanga V, Harding K (eds.). The Clinical Relevance of Wound Bed Preparation. Springer-Verlag GmbH & Co. KG. New York. 2002.
  110. Falanga V. Physiology and Pathophysiology of Wound Healing. Diabetic Foot: Medical and Surgical Treatment. Editors Veves A, Giurini J, LoGerfo F. Humana Press. Totowa, NJ. 2002; 59-73.
  111. Brem H, Balledux J, Sukkarieh T, Carson P, Falanga V. Healing of venous ulcers of long duration with a bilayered living skin substitute: results from a general surgery and dermatology department. Dermatol Surg. 2001 Nov; 27(11):915-9. PMID: 11737123.
    View in: PubMed
  112. Robson MC, Phillips TJ, Falanga V, Odenheimer DJ, Parish LC, Jensen JL, Steed DL. Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers. Wound Repair Regen. 2001 Sep-Oct; 9(5):347-52. PMID: 11896977.
    View in: PubMed
  113. Paquette D, Badiavas E, Falanga V. Short-contact topical tretinoin therapy to stimulate granulation tissue in chronic wounds. J Am Acad Dermatol. 2001 Sep; 45(3):382-6. PMID: 11511834.
    View in: PubMed
  114. Badiavas EV, Zhou L, Falanga V. Growth inhibition of primary keratinocytes following transduction with a novel TGFbeta-1 containing retrovirus. J Dermatol Sci. 2001 Sep; 27(1):1-6. PMID: 11457637.
    View in: PubMed
  115. Falanga V. The dark side of evidence-based wound management. J Wound Care. 2001 May; 10(5):145. PMID: 12964319.
    View in: PubMed
  116. Badiavas EV, Falanga V. Gene therapy. J Dermatol. 2001 Apr; 28(4):175-92. PMID: 11449669.
    View in: PubMed
  117. Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care. 2001 Feb; 24(2):290-5. PMID: 11213881.
    View in: PubMed
  118. de Imus G, Golomb C, Wilkel C, Tsoukas M, Nowak M, Falanga V. Accelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression. J Am Acad Dermatol. 2001 Jan; 44(1):61-6. PMID: 11148478.
    View in: PubMed
  119. Falanga V (ed.). Cutaneous Wound Healing. Martin Dunitz Publishers. London. 2001.
  120. Sibbald GR, Williamson D, Falanga V, Cherry GW. Venous Leg Ulcers. Chronic Wound Care. Eds. Krasner DL, Rodeheaver GT, Sibbald GR. HMP Communications. Wayne, PA. 2001; 483-494.
  121. de Imus FA Abigail, Falanga V. Advances in the Local Treatment of Venous Ulcers Using Bioengineered Skin. Handbook of Venus Disorders: Guidelines of the American Venous Forum. Eds. Gloviczki P, Yao JST. Parmenter Publishing Services. Evanston, IL. 2001; 322-328.
  122. Yamaguchi Y, Crane S, Zhou L, Ochoa SM, Falanga V. Lack of co-ordinate expression of the alpha1(I) and alpha1(III) procollagen genes in fibroblast clonal cultures. Br J Dermatol. 2000 Dec; 143(6):1149-53. PMID: 11122014.
    View in: PubMed
  123. Shen JT, Falanga V. Treatment of Venous Ulcers Using a Bilayered Living Skin Construct. Surg Technol Int. 2000 Oct; IX:77-80. PMID: 12219282.
    View in: PubMed
  124. Phillips TJ, Machado F, Trout R, Porter J, Olin J, Falanga V. Prognostic indicators in venous ulcers. J Am Acad Dermatol. 2000 Oct; 43(4):627-30. PMID: 11004617.
    View in: PubMed
  125. Falanga V. Classifications for wound bed preparation and stimulation of chronic wounds. Wound Repair Regen. 2000 Sep-Oct; 8(5):347-52. PMID: 11115147.
    View in: PubMed
  126. Gabel EA, Jimenez GP, Eaglstein WH, Kerdel FA, Falanga V. Performance comparison of nylon and an absorbable suture material (Polyglactin 910) in the closure of punch biopsy sites. Dermatol Surg. 2000 Aug; 26(8):750-2; discussion 752-3. PMID: 10940061.
    View in: PubMed
  127. Schonfeld WH, Villa KF, Fastenau JM, Mazonson PD, Falanga V. An economic assessment of Apligraf (Graftskin) for the treatment of hard-to-heal venous leg ulcers. Wound Repair Regen. 2000 Jul-Aug; 8(4):251-7. PMID: 11013015.
    View in: PubMed
  128. Falanga VJ. Tissue engineering in wound repair. Adv Skin Wound Care. 2000 May-Jun; 13(2 Suppl):15-9. PMID: 11074998.
    View in: PubMed
  129. Tokuda Y, Crane S, Yamaguchi Y, Zhou L, Falanga V. The levels and kinetics of oxygen tension detectable at the surface of human dermal fibroblast cultures. J Cell Physiol. 2000 Mar; 182(3):414-20. PMID: 10653608.
    View in: PubMed
  130. Nowak MA, Tsoukas MM, DeImus FA, Falanga V, Brodell RT. Generalized pruritus without primary lesions. Differential diagnosis and approach to treatment. Postgrad Med. 2000 Feb; 107(2):41-2, 45-6. PMID: 10689406.
    View in: PubMed
  131. Shen JT, Falanga V. Treatment of venous ulcers using a bilayered living skin construct. Surg Technol Int. 2000; 9:77-80. PMID: 21136391.
    View in: PubMed
  132. Falanga V. Scleroderma Update. Current Problems in Dermatology. Millenium Series. Editor Jeffery P. Callen. Mosby. St. Louis. 2000; 12(2):95-102.
  133. Falanga V. Growth Factors. The Foot in Diabetes. John Wiley & Sons. UK. 2000; 169-178.
  134. Shen JT, Falanga V. Treatment of Venous Ulcers Using a Bilayered Living Skin Construct. Surgical Technology International IX. Editors Szabo Z, Lewis JE, Fantini GA, and Savalgi RS. Universal Medical Press. San Francisco. 2000; 77-80.
  135. Falanga V with Phillips T, Harding K, Moy R, Peerson L. Text Atlas of Wound Healing. Martin Dunitz Publishers. London. 2000.
  136. Veves A, Falanga V. Diabetic Foot Ulcers: Prevention and Treatment. Wounds (Supplement). 2000.
  137. Falanga V, Fujitani RM, Diaz C, Hunter G, Jorizzo J, Lawrence PF, Lee BY, Menzoian JO, Tretbar LL, Holloway GA, Hoballah J, Seabrook GR, McMillan DE, Wolf W. Systemic treatment of venous leg ulcers with high doses of pentoxifylline: efficacy in a randomized, placebo-controlled trial. Wound Repair Regen. 1999 Jul-Aug; 7(4):208-13. PMID: 10781212.
    View in: PubMed
  138. Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen. 1999 Jul-Aug; 7(4):201-7. PMID: 10781211.
    View in: PubMed
  139. Falanga V. Becaplermin: a viewpoint by vincent falanga. BioDrugs. 1999 May; 11(5):366-7. PMID: 18031146.
    View in: PubMed
  140. Kirsner RS, Kerdel FA, Falanga V, Trent J, Eaglstein WH. The role of mandated research during dermatology residency training. J Invest Dermatol. 1999 Mar; 112(3):400-1. PMID: 10084326.
    View in: PubMed
  141. Falanga V . :Guest Editor for issue on Treatment of chronic wounds. Dermatologic Therapy. Munksgaard, Denmark. Vol. 9. 1999.
  142. Falanga V. Treatment Strategies for Venous Leg Ulcers. Practical Vascular Surgery. Editors Yao JST and Pierce WH. Appleton & Lange. Stamford, CT. 1999; 507-515.
  143. Measurements in Wound Healing. Mani R, Falanga V, Shearman C, Sandeman D (eds.). WB Saunders Co., Ltd. New York. 1999.
  144. Romanelli M, Falanga V. Measurements of Transcutaneous Oxygen Tension in Chronic Wounds. Measurements in Wound Healing. Eds. Mani R, Shearman C, Sandeman D, Falanga V. WB Saunders Co., Ltd. New York. 1999; 68-80.
  145. Shen J, Falanga V. Bioengineered Skin and Treatment of Wounds: Use of an Epidermal-dermal Construct (Apligraf). Today's Therapeutic Trends. 1999; 17:197-205.
  146. Falanga V. Care of venous leg ulcers. Ostomy Wound Manage. 1999 Jan; 45(1A Suppl):33S-43S; quiz 44S-45S. PMID: 10085974.
    View in: PubMed
  147. Eaglstein WH, Falanga V. Tissue engineering for skin: an update. J Am Acad Dermatol. 1998 Dec; 39(6):1007-10. PMID: 9843017.
    View in: PubMed
  148. Falanga V, Greenberg AS, Zhou L, Ochoa SM, Roberts AB, Falabella A, Yamaguchi Y. Stimulation of collagen synthesis by the anabolic steroid stanozolol. J Invest Dermatol. 1998 Dec; 111(6):1193-7. PMID: 9856839.
    View in: PubMed
  149. Falanga V. There is a new excitement these days in the way we view and treat chronic wounds. J Cutan Med Surg. 1998 Dec; 3 Suppl 1:before S1-1. PMID: 10328677.
    View in: PubMed
  150. Falanga V. Apligraf treatment of venous ulcers and other chronic wounds. J Dermatol. 1998 Dec; 25(12):812-7. PMID: 9990774.
    View in: PubMed
  151. Falanga V. Wound healing and chronic wounds. J Cutan Med Surg. 1998 Dec; 3 Suppl 1:S1-1-5. PMID: 10082600.
    View in: PubMed
  152. Falabella AF, Carson P, Eaglstein WH, Falanga V. The safety and efficacy of a proteolytic ointment in the treatment of chronic ulcers of the lower extremity. J Am Acad Dermatol. 1998 Nov; 39(5 Pt 1):737-40. PMID: 9810889.
    View in: PubMed
  153. Falabella A, Falanga V. Uncommon causes of ulcers. Clin Plast Surg. 1998 Jul; 25(3):467-79. PMID: 9696906.
    View in: PubMed
  154. Eaglstein WH, Falanga V. Tissue engineering and the development of Apligraf a human skin equivalent. Adv Wound Care. 1998 Jul-Aug; 11(4 Suppl):1-8. PMID: 10326339.
    View in: PubMed
  155. Eaglstein WH, Falanga V. Tissue engineering and the development of Apligraf, a human skin equivalent. Cutis. 1998 Jul; 62(1 Suppl):1-8. PMID: 9787994.
    View in: PubMed
  156. Ling MR, Swinyer LJ, Jarratt MT, Falo L, Monroe EW, Tharp M, Kalivas J, Weinstein GD, Asarch RG, Drake L, Martin AG, Leyden JJ, Cook J, Pariser DM, Pariser R, Thiers BH, Lebwohl MG, Babel D, Stewart DM, Eaglstein WH, Falanga V, Katz HI, Bergfeld WF, Hanifin JM, Young MR, et al. Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail. J Am Acad Dermatol. 1998 Jun; 38(6 Pt 2):S95-102. PMID: 9631991.
    View in: PubMed
  157. Kirsner RS, Falanga V, Eaglstein WH. The development of bioengineered skin. Trends Biotechnol. 1998 Jun; 16(6):246-9. PMID: 9652135.
    View in: PubMed
  158. Falanga V, Margolis D, Alvarez O, Auletta M, Maggiacomo F, Altman M, Jensen J, Sabolinski M, Hardin-Young J. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol. 1998 Mar; 134(3):293-300. PMID: 9521027.
    View in: PubMed
  159. Falabella A, Falanga V. Uncommon Causes of Ulcers. Clinics in Plastic Surgery. Wound Healing: State of the Art. Editors Granick MS, Long CD, Ramasastry SS. W.B. Saunders Co. Philadelphia. 1998; 467-479.
  160. Falanga V, Gottlieb ME, Omlie WR. Management of commonly misdiagnosed chronic wounds. In Treatment of Chronic Wounds Series. Number 8. Curative Health Services, Inc. 1998.
  161. Weiss E, Yamaguchi Y, Falabella A, Crane S, Tokuda Y, Falanga V. Un-cross-linked fibrin substrates inhibit keratinocyte spreading and replication: correction with fibronectin and factor XIII cross-linking. J Cell Physiol. 1998 Jan; 174(1):58-65. PMID: 9397156.
    View in: PubMed
  162. Guest Editor, Vincent Falanga, MD, J Cut Med Surg. Wound healing and chronic wounds. In Wound Care Supplement. 1998; 3.
  163. Falanga V. Management of Venous Leg Ulcers. Expanding Techniques in Treating Chronic Wounds. Editor Camerota AJ. Excerpta Medica, Inc., Reed Elsevier Co. Belle Mead, NJ. 1998; 14-21.
  164. Hasan A, Murata H, Falabella A, Ochoa S, Zhou L, Badiavas E, Falanga V. Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta 1. J Dermatol Sci. 1997 Nov; 16(1):59-66. PMID: 9438909.
    View in: PubMed
  165. Tallman P, Muscare E, Carson P, Eaglstein WH, Falanga V. Initial rate of healing predicts complete healing of venous ulcers. Arch Dermatol. 1997 Oct; 133(10):1231-4. PMID: 9382561.
    View in: PubMed
  166. Van de Scheur M, Falanga V. Pericapillary fibrin cuffs in venous disease. A reappraisal. Dermatol Surg. 1997 Oct; 23(10):955-9. PMID: 9357508.
    View in: PubMed
  167. Eaglstein WH, Falanga V. Tissue engineering and the development of Apligraf, a human skin equivalent. Clin Ther. 1997 Sep-Oct; 19(5):894-905. PMID: 9385478.
    View in: PubMed
  168. Eaglstein WH, Falanga V. Chronic wounds. Surg Clin North Am. 1997 Jun; 77(3):689-700. PMID: 9194887.
    View in: PubMed
  169. LeBlanc N, Falabella A, Murata H, Hasan A, Weiss E, Falanga V. Durometer measurements of skin induration in venous disease. Dermatol Surg. 1997 Apr; 23(4):285-7. PMID: 9149796.
    View in: PubMed
  170. Murata H, Zhou L, Ochoa S, Hasan A, Badiavas E, Falanga V. TGF-beta3 stimulates and regulates collagen synthesis through TGF-beta1-dependent and independent mechanisms. J Invest Dermatol. 1997 Mar; 108(3):258-62. PMID: 9036921.
    View in: PubMed
  171. Falanga V. Venous Ulceration. Chronic Wound Care: A Clinical Source Book for Health Care Professionals. Eds. Diane Krasner and Dean Kane. Health Management Publications, Inc. 1997; 165-171.
  172. Falanga V. Scleroderma. Skin Immune System (SIS). Editor Jan D. Bos. CRC Press LLC. 1997; 461-469.
  173. Kirsner RS, Spencer J, Falanga V, Garland LE, Kerdel FA. Squamous cell carcinoma arising in osteomyelitis and chronic wounds. Treatment with Mohs micrographic surgery vs amputation. Dermatol Surg. 1996 Dec; 22(12):1015-8. PMID: 9078313.
    View in: PubMed
  174. Bellman B, Reddy R, Falanga V. Generalized lichen planus associated with hepatitis C virus immunoreactivity. J Am Acad Dermatol. 1996 Nov; 35(5 Pt 1):770-2. PMID: 8912576.
    View in: PubMed
  175. Badiavas E, Mehta PP, Falanga V. Retrovirally mediated gene transfer in a skin equivalent model of chronic wounds. J Dermatol Sci. 1996 Oct; 13(1):56-62. PMID: 8902654.
    View in: PubMed
  176. Greenberg AS, Hasan A, Montalvo BM, Falabella A, Falanga V. Acute lipodermatosclerosis is associated with venous insufficiency. J Am Acad Dermatol. 1996 Oct; 35(4):566-8. PMID: 8859285.
    View in: PubMed
  177. Falanga V. Iodine-containing Pharmaceuticals: A Reappraisal. Proceedings of the 6th European Conference on Advances in Wound Management. Macmillan Magazines Ltd. London. 1996.
  178. Greenberg AS, Takagi H, Hill RH, Hasan A, Murata H, Falanga V. Delayed onset of skin fibrosis after the ingestion of eosinophilia-myalgia syndrome-associated L-tryptophan. J Am Acad Dermatol. 1996 Aug; 35(2 Pt 1):264-6. PMID: 8708033.
    View in: PubMed
  179. Kirsner RS, Falanga V, Kerdel FA, Katz MH, Eaglstein WH. Skin grafts as pharmacological agents: pre-wounding of the donor site. Br J Dermatol. 1996 Aug; 135(2):292-6. PMID: 8881677.
    View in: PubMed
  180. Falanga V, Carson P, Greenberg A, Hasan A, Nichols E, McPherson J. Topically applied recombinant tissue plasminogen activator for the treatment of venous ulcers. Preliminary report. Dermatol Surg. 1996 Jul; 22(7):643-4. PMID: 8680787.
    View in: PubMed
  181. Cai JP, Falanga V, Taylor JR, Chin YH. Transforming growth factor-beta receptor binding and function are decreased in psoriatic dermal endothelium. J Invest Dermatol. 1996 Feb; 106(2):225-31. PMID: 8601720.
    View in: PubMed
  182. Cai JP, Harris K, Falanga V, Taylor JR, Chin YH. UVB therapy decreases the adhesive interaction between peripheral blood mononuclear cells and dermal microvascular endothelium, and regulates the differential expression of CD54, VCAM-1, and E-selectin in psoriatic plaques. Br J Dermatol. 1996 Jan; 134(1):7-16. PMID: 8745879.
    View in: PubMed
  183. Greenberg SA, Falanga V. Localized Cutaneous Sclerosis. Cutaneous Manifestations of Rheumatic Diseases. Eds. Sontheimer RD, Provost TT. Williams & Wilkins. Philadelphia. 1996; 141-155.
  184. Falanga V. Scleroderma Syndromes. Principles and Practice of Dermatology. W. Mitchell Sams, Jr. and Peter J. Lynch, editors. Churchill Livingstone. New York. 1996; 607-617.
  185. Bellman B, Reddy RK, Falanga V. Lichen planus associated with hepatitis C. Lancet. 1995 Nov 4; 346(8984):1234. PMID: 7475692.
    View in: PubMed
  186. Takagi H, Ochoa MS, Zhou L, Helfman T, Murata H, Falanga V. Enhanced collagen synthesis and transcription by peak E, a contaminant of L-tryptophan preparations associated with the eosinophilia myalgia syndrome epidemic. J Clin Invest. 1995 Nov; 96(5):2120-5. PMID: 7593596.
    View in: PubMed
  187. Laszlo KS, Falanga V, Kerdel FA. Idiopathic palmar fasciitis. Int J Dermatol. 1995 Sep; 34(9):658-60. PMID: 7591472.
    View in: PubMed
  188. Helfman T, Falanga V. Stanozolol as a novel therapeutic agent in dermatology. J Am Acad Dermatol. 1995 Aug; 33(2 Pt 1):254-8. PMID: 7622653.
    View in: PubMed
  189. Kirsner RS, Mata SM, Falanga V, Kerdel FA. Split-thickness skin grafting of leg ulcers. The University of Miami Department of Dermatology's experience (1990-1993). Dermatol Surg. 1995 Aug; 21(8):701-3. PMID: 7633815.
    View in: PubMed
  190. Falanga V, Zhou LH, Takagi H, Murata H, Ochoa S, Martin TA, Helfman T. Human dermal fibroblast clones derived from single cells are heterogeneous in the production of mRNAs for alpha 1(I) procollagen and transforming growth factor-beta 1. J Invest Dermatol. 1995 Jul; 105(1):27-31. PMID: 7615971.
    View in: PubMed
  191. Falanga V, Grinnel F, Gilchrest B, Maddox YT, Moshell A. Experimental approaches to chronic wounds. Wound Repair Regen. 1995 Apr-Jun; 3(2):132-40. PMID: 17173642.
    View in: PubMed
  192. Romanelli M, Falanga V. Use of a durometer to measure the degree of skin induration in lipodermatosclerosis. J Am Acad Dermatol. 1995 Feb; 32(2 Pt 1):188-91. PMID: 7829701.
    View in: PubMed
  193. Pardes J, Falanga V. Leg Ulcers. Current Practice of Medicine. Ed. Roger C. Bone. Dermatology Section Ed. Callen J. Current Medicine. Philadelphia. 1995; 87-95.
  194. Higley HR, Ksander GA, Gerhardt CO, Falanga V. Extravasation of macromolecules and possible trapping of transforming growth factor-beta in venous ulceration. Br J Dermatol. 1995 Jan; 132(1):79-85. PMID: 7538779.
    View in: PubMed
  195. Pardes JB, Takagi H, Martin TA, Ochoa MS, Falanga V. Decreased levels of alpha 1(I) procollagen mRNA in dermal fibroblasts grown on fibrin gels and in response to fibrinopeptide B. J Cell Physiol. 1995 Jan; 162(1):9-14. PMID: 7814454.
    View in: PubMed
  196. Falanga V, Eaglstein WH. Leg and foot ulcers: A clinician's guide. Martin Dunitz publisher, London. 1995; 182 pages.
  197. Falanga V. Scleroderma, Raynaud's Phenomenon, and Related Conditions. Dermatologic Signs of Internal Disease. Ed. Callen J et al. W.B. Saunders Company. Philadelphia. 1995; 21-30.
  198. Falanga V, Schachner LA, Rae V, Ceballos PI, Gonzalez A, Liang G, Banks R. Dermatologic consultations in the hospital setting. Arch Dermatol. 1994 Aug; 130(8):1022-5. PMID: 8053699.
    View in: PubMed
  199. Falanga V, Takagi H, Ceballos PI, Pardes JB. Low oxygen tension decreases receptor binding of peptide growth factors in dermal fibroblast cultures. Exp Cell Res. 1994 Jul; 213(1):80-4. PMID: 8020609.
    View in: PubMed
  200. Helfman T, Falanga V. Eosinophilic fasciitis. Clin Dermatol. 1994 Jul-Sep; 12(3):449-55. PMID: 7954202.
    View in: PubMed
  201. Basso A, Pardes J, Helfman T, Peerson LJ, Falanga V. Adaptation of a pressure relief dressing for the treatment of leg ulcers. J Am Acad Dermatol. 1994 May; 30(5 Pt 1):779-80. PMID: 8176019.
    View in: PubMed
  202. Falanga V, Grinnell F, Gilchrest B, Maddox YT, Moshell A. Workshop on the pathogenesis of chronic wounds. J Invest Dermatol. 1994 Jan; 102(1):125-7. PMID: 8288905.
    View in: PubMed
  203. Helfman T, Ovington L, Falanga V. Occlusive dressings and wound healing. Clin Dermatol. 1994 Jan-Mar; 12(1):121-7. PMID: 8180934.
    View in: PubMed
  204. Helfman T, Ovington L, Falanga V. Occlusive Dressings and Wound Healing. Clinics of Dermatology. Ed. Eric F. Bernstein. Elsevier. 1994; 12(1):121-127.
  205. Helfman T, Falanga V. Eosinophilic Fasciitis. Clinics in Dermatology. Scleroderma: From Morphea to Systemic Sclerosis. Eds. Lotti T, Matucci-Cerinic M. 1994; 12:449-455.
  206. Pardes JB, Falanga V, Kerdel FA. Delayed cutaneous ulcerations arising at sites of prior parenteral drug abuse. J Am Acad Dermatol. 1993 Dec; 29(6):1052-4. PMID: 8245248.
    View in: PubMed
  207. Falanga V, Martin TA, Takagi H, Kirsner RS, Helfman T, Pardes J, Ochoa MS. Low oxygen tension increases mRNA levels of alpha 1 (I) procollagen in human dermal fibroblasts. J Cell Physiol. 1993 Nov; 157(2):408-12. PMID: 8227170.
    View in: PubMed
  208. Falanga V. Growth factors and wound healing. Dermatol Clin. 1993 Oct; 11(4):667-75. PMID: 8222350.
    View in: PubMed
  209. Pardes JB, Carson PA, Eaglstein WH, Falanga V. Mupirocin treatment of exudative venous ulcers. J Am Acad Dermatol. 1993 Sep; 29(3):497-8. PMID: 8349875.
    View in: PubMed
  210. Falanga V. Venous ulceration. J Dermatol Surg Oncol. 1993 Aug; 19(8):764-71. PMID: 8349918.
    View in: PubMed
  211. Kirsner RS, Falanga V. Techniques of split-thickness skin grafting for lower extremity ulcerations. J Dermatol Surg Oncol. 1993 Aug; 19(8):779-83. PMID: 7794287.
    View in: PubMed
  212. Falanga V. Growth factors and wound healing. J Dermatol Surg Oncol. 1993 Aug; 19(8):711-4. PMID: 8349910.
    View in: PubMed
  213. Falanga V. Wound healing. An overview. J Dermatol Surg Oncol. 1993 Aug; 19(8):689-90. PMID: 8349908.
    View in: PubMed
  214. Falanga V, Bucalo B. Use of a durometer to assess skin hardness. J Am Acad Dermatol. 1993 Jul; 29(1):47-51. PMID: 8315077.
    View in: PubMed
  215. Bucalo B, Eaglstein WH, Falanga V. Inhibition of cell proliferation by chronic wound fluid. Wound Repair Regen. 1993 Jul; 1(3):181-6. PMID: 17163887.
    View in: PubMed
  216. Helfman T, Falanga V. Gene expression in low oxygen tension. Am J Med Sci. 1993 Jul; 306(1):37-41. PMID: 8328508.
    View in: PubMed
  217. Falanga V. Chronic wounds: pathophysiologic and experimental considerations. J Invest Dermatol. 1993 May; 100(5):721-5. PMID: 8491995.
    View in: PubMed
  218. Falanga V, Eaglstein WH. The "trap" hypothesis of venous ulceration. Lancet. 1993 Apr 17; 341(8851):1006-8. PMID: 7682272.
    View in: PubMed
  219. Kirsner RS, Falanga V, Eaglstein WH. The biology of skin grafts. Skin grafts as pharmacologic agents. Arch Dermatol. 1993 Apr; 129(4):481-3. PMID: 8466221.
    View in: PubMed
  220. Kirsner RS, Pardes JB, Eaglstein WH, Falanga V. The clinical spectrum of lipodermatosclerosis. J Am Acad Dermatol. 1993 Apr; 28(4):623-7. PMID: 8463465.
    View in: PubMed
  221. Kirsner RS, Goodless D, Kerdel FA, Pardes JB, Falanga V. Enlargement of the hands and feet in a chronic smoker. Arthritis Rheum. 1993 Apr; 36(4):569-71. PMID: 8457231.
    View in: PubMed
  222. Falanga V, Kirsner RS. Low oxygen stimulates proliferation of fibroblasts seeded as single cells. J Cell Physiol. 1993 Mar; 154(3):506-10. PMID: 8436599.
    View in: PubMed
  223. Falanga V. The "wrinkle test": clinical use for detecting early epidermal resurfacing. J Dermatol Surg Oncol. 1993 Feb; 19(2):172-3. PMID: 8429148.
    View in: PubMed
  224. Harris B, Eaglstein WH, Falanga V. Basal cell carcinoma arising in venous ulcers and mimicking granulation tissue. J Dermatol Surg Oncol. 1993 Feb; 19(2):150-2. PMID: 8429142.
    View in: PubMed
  225. Kirsner RS, Eaglstein WH, Katz MH, Kerdel FA, Falanga V. Stanozolol causes rapid pain relief and healing of cutaneous ulcers caused by cryofibrinogenemia. J Am Acad Dermatol. 1993 Jan; 28(1):71-4. PMID: 8425973.
    View in: PubMed
  226. Falanga V (ed.). Practical Aspects of Wound Healing. Special issue of the J Dermatol Surg Oncol. 1993; 19.
  227. Kirsner RS, Pardes JB, Falanga V. Solitary fibrosing paraspinal plaque: solitary morphoea profunda? Br J Dermatol. 1993 Jan; 128(1):99-101. PMID: 8427830.
    View in: PubMed
  228. Falanga V. Special Issue on Wound Healing: An Overview. Practical Aspects of Wound Healing, ed. Falanga V. Special issue of the J Dermatol Surg Oncol. 1993; 19.
  229. Falanga V. Growth Factors and Wound Healing. New Trends in Dermatologic Surgery. Eds. Roegnik RK, Roegnik HH. Martin Dunitz. London. 1993; 47-54.
  230. Falanga V. Growth Factors and Wound Healing. Dermatologic Clinics. Ed. Nemeth AJ. W.B. Saunders Company. 1993; 11:667-675.
  231. Growth Factors in Wound Healing and Fibrosis. Dermatology. Progress and Perspectives. Eds. Burgdorf WHC and Katz SI. The Parthenon Publishing Group LTD. New York. 1993; 421-426.
  232. Falanga V. Growth factors and chronic wounds: the need to understand the microenvironment. J Dermatol. 1992 Nov; 19(11):667-72. PMID: 1293152.
    View in: PubMed
  233. Falanga V, Katz MH, Kirsner R, Alvarez AF. The effects of endothelin-1 on human dermal fibroblast growth and synthetic activity. J Surg Res. 1992 Nov; 53(5):515-9. PMID: 1434602.
    View in: PubMed
  234. Kirsner RS, Falanga V. Features of an autoimmune process in mid-dermal elastolysis. J Am Acad Dermatol. 1992 Nov; 27(5 Pt 2):832-4. PMID: 1469138.
    View in: PubMed
  235. Falanga V, Eaglstein WH, Bucalo B, Katz MH, Harris B, Carson P. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers. J Dermatol Surg Oncol. 1992 Jul; 18(7):604-6. PMID: 1624634.
    View in: PubMed
  236. Falanga V, Gerhardt CO, Dasch JR, Takehara K, Ksander GA. Skin distribution and differential expression of transforming growth factor beta 1 and beta 2. J Dermatol Sci. 1992 May; 3(3):131-6. PMID: 1498091.
    View in: PubMed
  237. Falanga V, Kirsner R, Katz MH, Gould E, Eaglstein WH, McFalls S. Pericapillary fibrin cuffs in venous ulceration. Persistence with treatment and during ulcer healing. J Dermatol Surg Oncol. 1992 May; 18(5):409-14. PMID: 1607464.
    View in: PubMed
  238. Cai JP, Falanga V, Taylor JR, Chin YH. Transforming growth factor-beta differentially regulates the adhesiveness of normal and psoriatic dermal microvascular endothelial cells for peripheral blood mononuclear cells. J Invest Dermatol. 1992 Apr; 98(4):405-9. PMID: 1548425.
    View in: PubMed
  239. Harris B, Cai JP, Falanga V, Mertz P, Chin YH, Eaglstein W. The effects of occlusive dressings on the recruitment of mononuclear cells by endothelial binding into acute wounds. J Dermatol Surg Oncol. 1992 Apr; 18(4):279-83. PMID: 1560151.
    View in: PubMed
  240. Rothe MJ, Falanga V. Growth Factors and Wound Healing. Clinics in Dermatology. 1992; 9:553-559.
  241. Falanga V. Transforming Growth Factor-Beta (TGF-Beta): The Potential for Fibrosis and the Realities. Scleroderma International Symposium - Current Topics in Scleroderma. Eds. Maeda M and Ogawa I. Seino Printing Company, Ltd. Gifu City, Japan. 1992; 171-179.
  242. Falanga V. Chronic Wounds: Pathophysiologic and Experimental Considerations. Progress in Dermatology. 1992; 26(4):1992.
  243. Katz MH, Alvarez AF, Kirsner RS, Eaglstein WH, Falanga V. Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth. J Am Acad Dermatol. 1991 Dec; 25(6 Pt 1):1054-8. PMID: 1810982.
    View in: PubMed
  244. Falanga V, Kruskal JB, Franks JJ. Fibrin and fibrinogen-related antigens in systemic sclerosis (scleroderma) J Am Acad Dermatol. 1991 Nov; 25(5 Pt 1):771-5. PMID: 1802898.
    View in: PubMed
  245. Nemeth AJ, Eaglstein WH, Taylor JR, Peerson LJ, Falanga V. Faster healing and less pain in skin biopsy sites treated with an occlusive dressing. Arch Dermatol. 1991 Nov; 127(11):1679-83. PMID: 1952972.
    View in: PubMed
  246. Rothe MJ, Falanga V. Growth factors and wound healing. Clin Dermatol. 1991 Oct-Dec; 9(4):553-9. PMID: 1822411.
    View in: PubMed
  247. Falanga V, Qian SW, Danielpour D, Katz MH, Roberts AB, Sporn MB. Hypoxia upregulates the synthesis of TGF-beta 1 by human dermal fibroblasts. J Invest Dermatol. 1991 Oct; 97(4):634-7. PMID: 1940433.
    View in: PubMed
  248. Falanga V, Kirsner RS, Eaglstein WH, Katz MH, Kerdel FA. Stanozolol in treatment of leg ulcers due to cryofibrinogenaemia. Lancet. 1991 Aug 10; 338(8763):347-8. PMID: 1677702.
    View in: PubMed
  249. Cai JP, Falanga V, Chin YH. Transforming growth factor-beta regulates the adhesive interactions between mononuclear cells and microvascular endothelium. J Invest Dermatol. 1991 Aug; 97(2):169-74. PMID: 2071932.
    View in: PubMed
  250. Blauvelt A, Falanga V. Idiopathic and L-tryptophan-associated eosinophilic fasciitis before and after L-tryptophan contamination. Arch Dermatol. 1991 Aug; 127(8):1159-66. PMID: 1863073.
    View in: PubMed
  251. Falanga V, Katz MH, Goodless DR. Proliferation and collagen synthesis by human dermal fibroblasts cultured from different body sites. J Dermatol Sci. 1991 May; 2(3):166-70. PMID: 1878345.
    View in: PubMed
  252. Romanelli M, Katz MH, Alvarez AF, Eaglstein WH, Falanga V. The effect of topical nitroglycerin on transcutaneous oxygen. Br J Dermatol. 1991 Apr; 124(4):354-7. PMID: 1902742.
    View in: PubMed
  253. Falanga V, McKenzie A, Eaglstein WH. Heterogeneity in oxygen diffusion around venous ulcers. J Dermatol Surg Oncol. 1991 Apr; 17(4):336-9. PMID: 2040746.
    View in: PubMed
  254. Falanga V. Fibrosing Syndromes of Childhood. Advancs in Dermatology. Mosby Year Book. St. Louis, MO. 1991; 6:145-159.
  255. Falanga V, Katz MH. Clinical spectrum of venous disease. Prog Clin Biol Res. 1991; 365:19-25. PMID: 1862131.
    View in: PubMed
  256. Cai JP, Harris B, Falanga V, Eaglstein WH, Mertz PM, Chin YH. Recruitment of mononuclear cells into wounded skin: mechanism and modulation. Prog Clin Biol Res. 1991; 365:243-56. PMID: 1862136.
    View in: PubMed
  257. Nemeth AJ, Eaglstein WH, Falanga V, Hevia O, Taylor RJ. Methods to Speed Healing after Skin Biopsy or Trichloroacetic Acid Chemical Peel. Clinical and Experimental Approach to Dermal and Epidermal Repair. Eds. Barbul A, Caldwell MD, Eaglstein WH, Hunt TK, Marshall D, Pines E, Skover G. Wiley-Liss. New York. 1991; 267-277.
  258. Falanga V. Growth Factors: Status and Expectations. International Symposium on Wound Management. Ed. Leaper DJ. Medicom Europe. The Netherlands. 1991; 87-93.
  259. Nemeth AJ, Eaglstein WH, Falanga V, Hevia O, Taylor JR. Methods to speed healing after skin biopsy or trichloroacetic acid chemical peel. Prog Clin Biol Res. 1991; 365:267-77. PMID: 1862138.
    View in: PubMed
  260. Falanga V, Kruskal J, Franks JJ. Fibrin- and fibrinogen-related antigens in patients with venous disease and venous ulceration. Arch Dermatol. 1991 Jan; 127(1):75-8. PMID: 1986710.
    View in: PubMed
  261. Katz MH, Falanga V, Eaglstein WH. Leg Ulcers: A Wound Healing Model. Recent Advances in Dermatology, eds. Champion RH and Pye RJ. Churchill Livingstone. New York. 1991; 9:199-218.
  262. Falanga V. Fibrosing conditions in childhood. Adv Dermatol. 1991; 6:145-58; discussion 159. PMID: 1983952.
    View in: PubMed
  263. Falanga V, Katz MH. Clinical Spectrum of Venous Disease. Clinical and Experimental Approaches to Dermal and Epidermal Repair. Eds Barbul A, Caldwell MD, Eaglstein WH, Hunt TK, Marshall D, Pines E, Skover G. Wiley-Liss. New York. 1991; 19-25.
  264. Eaglstein WH, Mertz PM, Falanga V. Wound dressings: current and future. Prog Clin Biol Res. 1991; 365:257-65. PMID: 1862137.
    View in: PubMed
  265. Chin YH, Falanga V, Cai JP. Lymphocyte adhesion to psoriatic dermal endothelium: mechanism and modulation. J Invest Dermatol. 1990 Nov; 95(5):29S-31S. PMID: 2230204.
    View in: PubMed
  266. Chin YH, Falanga V, Cai JP. Lymphocyte adhesion to psoriatic dermal endothelium: mechanism and modulation. J Invest Dermatol. 1990 Nov; 95(5 Suppl):29S-31S. PMID: 16788626.
    View in: PubMed
  267. Cai JP, Harris B, Falanga V, Eaglstein WH, Mertz PM, Chin YH. Recruitment of mononuclear cells by endothelial cell binding into wounded skin is a selective, time-dependent process with defined molecular interactions. J Invest Dermatol. 1990 Oct; 95(4):415-21. PMID: 2212726.
    View in: PubMed
  268. Falanga V, Bontempo FA, Eaglstein WH. Protein C and protein S plasma levels in patients with lipodermatosclerosis and venous ulceration. Arch Dermatol. 1990 Sep; 126(9):1195-7. PMID: 2144413.
    View in: PubMed
  269. Falanga V, Iriondo M. Zinc chloride paste for the debridement of chronic leg ulcers. J Dermatol Surg Oncol. 1990 Jul; 16(7):658-61. PMID: 2362028.
    View in: PubMed
  270. Pathy AL, Rae V, Falanga V. Subcutaneous calcification in venous ulcers: report of a case. J Dermatol Surg Oncol. 1990 May; 16(5):450-2. PMID: 2341659.
    View in: PubMed
  271. Falanga V, Medsger TA. D-penicillamine in the treatment of localized scleroderma. Arch Dermatol. 1990 May; 126(5):609-12. PMID: 2334179.
    View in: PubMed
  272. Chin YH, Falanga V, Taylor JR, Cai JP, Bax J. Adherence of human helper/memory T-cell subsets to psoriatic dermal endothelium. J Invest Dermatol. 1990 Apr; 94(4):413-7. PMID: 1968932.
    View in: PubMed
  273. Falanga V, Soter NA, Altman RD, Kerdel FA. Elevated plasma histamine levels in systemic sclerosis (scleroderma). Arch Dermatol. 1990 Mar; 126(3):336-8. PMID: 2310207.
    View in: PubMed
  274. Falanga V. Scleroderma Syndromes. Textbook of Dermatology. Mitchell Sams, P. Lynch, eds. Churchill Livingstone Inc. New York. 1990; 589-599.
  275. Falanga V, Julien JM. Observations in the potential role of transforming growth factor-beta in cutaneous fibrosis. Systemic sclerosis. Ann N Y Acad Sci. 1990; 593:161-71. PMID: 2165374.
    View in: PubMed
  276. Weiss DS, Eaglstein WH, Falanga V. Exogenous electric current can reduce the formation of hypertrophic scars. J Dermatol Surg Oncol. 1989 Dec; 15(12):1272-5. PMID: 2592666.
    View in: PubMed
  277. Rothe M, Falanga V. Growth factors. Their biology and promise in dermatologic diseases and tissue repair. Arch Dermatol. 1989 Oct; 125(10):1390-8. PMID: 2679401.
    View in: PubMed
  278. Falanga V. Localized scleroderma. Med Clin North Am. 1989 Sep; 73(5):1143-56. PMID: 2671537.
    View in: PubMed
  279. Liang G, Pardo RJ, Voigt W, Gould EW, Falanga V. Studies of immunoglobulin and T cell receptor gene rearrangement in cutaneous B and T cell lymphomas. J Am Acad Dermatol. 1989 Sep; 21(3 Pt 1):457-60. PMID: 2789234.
    View in: PubMed
  280. Chin YH, Falanga V, Streilein JW, Sackstein R. Lymphocyte recognition of psoriatic endothelium: evidence for a tissue-specific receptor/ligand interaction. J Invest Dermatol. 1989 Aug; 93(2 Suppl):82S-87S. PMID: 2546996.
    View in: PubMed
  281. Rae V, Falanga V. Wrinkling due to middermal elastolysis. Report of a case and review of the literature. Arch Dermatol. 1989 Jul; 125(7):950-1. PMID: 2525896.
    View in: PubMed
  282. Falanga V, Soter NA, Kerdel FA. Increased plasma histamine level in eosinophilic fasciitis. Arch Dermatol. 1989 Jun; 125(6):805-8. PMID: 2730101.
    View in: PubMed
  283. Aly R, Maibach HI, Bagatell FK, Dittmar W, Hänel H, Falanga V, Leyden JJ, Roth HL, Stoughton RB, Willis I, et al. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis. Clin Ther. 1989 May-Jun; 11(3):290-303. PMID: 2663159.
    View in: PubMed
  284. Rae V, Pardo RJ, Blackwelder PL, Falanga V. Leg ulcers following subcutaneous injection of a liquid silicone preparation. Arch Dermatol. 1989 May; 125(5):670-3. PMID: 2712585.
    View in: PubMed
  285. Nemeth AJ, Eaglstein WH, Falanga V. Clinical parameters and transcutaneous oxygen measurements for the prognosis of venous ulcers. J Am Acad Dermatol. 1989 Feb; 20(2 Pt 1):186-90. PMID: 2915052.
    View in: PubMed
  286. Nemeth AJ, Falanga V, Alstadt SP, Eaglstein WH. Ulcerated edematous limbs: effect of edema removal on transcutaneous oxygen measurements. J Am Acad Dermatol. 1989 Feb; 20(2 Pt 1):191-7. PMID: 2915053.
    View in: PubMed
  287. Falanga V. Localized Scleroderma. Collagen Vascular Diseases. Medical Clinics of North America. Callen JP, (ed). W.B. Saunders Co. Philadelphia. 1989; 73(5):1143-1156.
  288. Falanga V, Eaglstein WH. Practical Management of Leg Ulcers in the Elderly. Geriatric Dermatology: Clinical Diagnosis and Practical Therapy. Victor D. Newcomer, Edward M. Young, eds. Igaku-Shoin. New York. 1989; 503-510.
  289. Falanga V. Venous Ulcers and Other Cutaneous Ulcerations. Conn's Current Therapy. Robert E. Rakel, ed. W.B. Saunders Co. Philadelphia. 1989; 743-747.
  290. Sackstein R, Falanga V, Streilein JW, Chin YH. Lymphocyte adhesion to psoriatic dermal endothelium is mediated by a tissue-specific receptor/ligand interaction. J Invest Dermatol. 1988 Nov; 91(5):423-8. PMID: 3262692.
    View in: PubMed
  291. Rothe MJ, Altman RD, Falanga V. Plasma somatomedin-C levels in systemic sclerosis. Br J Dermatol. 1988 Nov; 119(5):639-42. PMID: 3207616.
    View in: PubMed
  292. Falanga V, Zitelli JA, Eaglstein WH. Wound healing. J Am Acad Dermatol. 1988 Sep; 19(3):559-63. PMID: 3170815.
    View in: PubMed
  293. Silverstein JL, Steen VD, Medsger TA, Falanga V. Cutaneous hypoxia in patients with systemic sclerosis (scleroderma). Arch Dermatol. 1988 Sep; 124(9):1379-82. PMID: 3415281.
    View in: PubMed
  294. Chin YH, Falanga V, Streilein JW, Sackstein R. Specific lymphocyte-endothelial cell interactions regulate migration into lymph nodes, Peyer's patches, and skin. Reg Immunol. 1988 Jul-Aug; 1(1):78-83. PMID: 3079311.
    View in: PubMed
  295. Falanga V. Occlusive wound dressings. Why, when, which? Arch Dermatol. 1988 Jun; 124(6):872-7. PMID: 3288123.
    View in: PubMed
  296. Falanga V, Alstadt SP. Effect of a platelet release fraction on glycosaminoglycan synthesis by cultured dermal fibroblasts from patients with progressive systemic sclerosis. Br J Dermatol. 1988 Mar; 118(3):339-45. PMID: 3355777.
    View in: PubMed
  297. Falanga V, Eaglstein WH. Wound Healing: Practical Aspects. Progress in Dermatology. 1988; 22:1-10.
  298. Falanga V. Venous Ulcers and Other Cutaneous Ulcerations. Conn's Current Therapy. Robert E. Rakel, ed. W.B. Saunders Company. Philadelphia. 1988; 719-722.
  299. Eaglstein WH, Falanga V, Nemeth A, Moosa H. Pericapillary fibrin, venous ulcers, and transcutaneous oxygen. Fibrinolysis and angiogenesis in wound healing. Cederholm-Williams SA, Ryan TJ, Lydon MJ, editors. Excerpta Medica, Elsevier Co. Princeton, NJ. 1988; 12-15.
  300. Fine MJ, Kapoor W, Falanga V. Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology. 1987 Oct; 38(10):769-84. PMID: 3310742.
    View in: PubMed
  301. Falanga V, Medsger TA. Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis. J Am Acad Dermatol. 1987 Oct; 17(4):648-56. PMID: 3668010.
    View in: PubMed
  302. Falanga V, Tiegs SL, Alstadt SP, Roberts AB, Sporn MB. Transforming growth factor-beta: selective increase in glycosaminoglycan synthesis by cultures of fibroblasts from patients with progressive systemic sclerosis. J Invest Dermatol. 1987 Jul; 89(1):100-4. PMID: 3496398.
    View in: PubMed
  303. Moosa HH, Falanga V, Steed DL, Makaroun MS, Peitzman AB, Eaglstein WH, Webster MW. Oxygen diffusion in chronic venous ulceration. J Cardiovasc Surg (Torino). 1987 Jul-Aug; 28(4):464-7. PMID: 3597541.
    View in: PubMed
  304. Falanga V, Moosa HH, Nemeth AJ, Alstadt SP, Eaglstein WH. Dermal pericapillary fibrin in venous disease and venous ulceration. Arch Dermatol. 1987 May; 123(5):620-3. PMID: 3555351.
    View in: PubMed
  305. Falanga V, Medsger TA, Reichlin M. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol. 1987 Mar; 123(3):350-3. PMID: 3545090.
    View in: PubMed
  306. Eaglstein WH, Mertz PM, Falanga V. Occlusive dressings. Am Fam Physician. 1987 Mar; 35(3):211-6. PMID: 3825848.
    View in: PubMed
  307. Falanga V, Fine MJ, Kapoor WN. The cutaneous manifestations of cholesterol crystal embolization. Arch Dermatol. 1986 Oct; 122(10):1194-8. PMID: 3767406.
    View in: PubMed
  308. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A. 1986 Jun; 83(12):4167-71. PMID: 2424019.
    View in: PubMed
  309. Falanga V, Medsger TA, Reichlin M, Rodnan GP. Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med. 1986 Jun; 104(6):849-57. PMID: 3486617.
    View in: PubMed
  310. Falanga V, Eaglstein WH. A therapeutic approach to venous ulcers. J Am Acad Dermatol. 1986 May; 14(5 Pt 1):777-84. PMID: 3519695.
    View in: PubMed
  311. Falanga V, Eaglstein WH. Management of venous ulcers. Am Fam Physician. 1986 Feb; 33(2):274-81. PMID: 2936224.
    View in: PubMed
  312. Falanga V. Infantile acropustulosis with eosinophilia. J Am Acad Dermatol. 1985 Nov; 13(5 Pt 1):826-8. PMID: 4078080.
    View in: PubMed
  313. Falanga V, Campbell DE, Leyden JJ, Douglas SD. Nasal carriage of Staphylococcus aureus and antistaphylococcal immunoglobulin E antibodies in atopic dermatitis. J Clin Microbiol. 1985 Sep; 22(3):452-4. PMID: 4044803.
    View in: PubMed
  314. Falanga V, Hebda PA, Eaglstein WH. Effect of platelet homogenate on in vitro glycosaminoglycans production by dermal fibroblasts from systemic sclerosis patients and normal controls. Br J Dermatol. 1985 Aug; 113(2):237-43. PMID: 4027190.
    View in: PubMed
  315. Falanga V, Medsger TA, Reichlin M. High titers of antibodies to single-stranded DNA in linear scleroderma. Arch Dermatol. 1985 Mar; 121(3):345-7. PMID: 3883904.
    View in: PubMed
  316. Falanga V, Kapoor W. Cerebral cysticercosis: diagnostic value of subcutaneous nodules. Report of two cases. J Am Acad Dermatol. 1985 Feb; 12(2 Pt 1):304-7. PMID: 3973125.
    View in: PubMed
  317. Check JH, Gentlesk MJ, Falanga V. Sympathomimetic amines in the treatment of chronic urticaria: two case reports. Cutis. 1984 Oct; 34(4):388-90. PMID: 6488891.
    View in: PubMed
  318. Falanga V, Zheng P, Lavker RM. Ultrastructural study of iron deposition in the eccrine sweat glands of patients with iron overload. Br J Dermatol. 1984 Jan; 110(1):51-6. PMID: 6691917.
    View in: PubMed
  319. Caralis PV, Falanga V, Pardo V. Delayed form of Wegener's granulomatosis. South Med J. 1981 Jul; 74(7):882-3. PMID: 7256338.
    View in: PubMed
Vincent's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department